Journal Club 2012


 PDF-Link for institution's members only (password required, see infoboard of UVCM, Inselspital)

11-07-2012

Ciclosporin versus infliximab in colitis ulcerosa:

  • Laharie D. et al.: Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012 Oct 9. pii: S0140-6736(12)61084-8.
 http://www.ncbi.nlm.nih.gov/pubmed/23063316

10-24-2012

Proton pump inhibitor and SIBO
:

Celiac disease and pancreatitis
:


10-10-2012

Infections and mortality in Crohn`s disease:

  • 
Lichtenstein et al.: Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol. 2006 May;4(5):621-30. 
http://www.ncbi.nlm.nih.gov/pubmed/16678077

IBS symptoms in IBD:


  • Halpin SJ et al. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.Am J Gastroenterol. 2012 Oct;107(10):1474-82. 
http://www.ncbi.nlm.nih.gov/pubmed/22929759

09-26-2012

Eltrombopag before procedures in cirrhosis:


Short course Terlipressin in acute variceal bleeding:


09-12-2012

Tofacitinib in active Ulcerative Colitis
:


BMI and colorectal adenomas:

Okabayashi K et al.: Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012 Aug;107(8):1175-85.
http://www.ncbi.nlm.nih.gov/pubmed/22733302


08-15-2012

Expandable stents for malignant esophageal disease
:

Neoadjuvant chemoradiotherapy for esophageal or junctional cancer:


07-18-2012

Safety of long-term infliximab treatment, with/without concomitant immunomodulators
:

  • Lichtenstein et al.: A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease. Am J Gastroenterol. 2012 Jul;107(7):1051-63.
 http://www.ncbi.nlm.nih.gov/pubmed/22613901

Fecal micobiota transplant for recurrent clostridium difficile infection:

  • Brandt et al.: Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent clostridium difficile infection. Am J Gastroenterol. 2012 Jul;107(7):1079-87.
http://www.ncbi.nlm.nih.gov/pubmed/22450732

06-27-2012

Diet in therapy of eosinophilic esophagitis


  • Gonsalves et al.: Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451-1459.
http://www.ncbi.nlm.nih.gov/pubmed/22391333

Rifaximin in patients with crohn disease

  • 
Prantera et al.: Rifaximin-extended intestinal release induces remission in patients with
moderately active crohn’s disease. Gastroenterology 2012;142:473–481.
http://www.ncbi.nlm.nih.gov/pubmed/22155172

06-20-2012

Outcome of pregnant IBD patients treated with thiopurines:

Risk factors for endoscopic removal of colorectal tumors:

  • Meining et. al.: Risk factors for unfavorable outcomes after endoscopic removal of submucosal invasive colorectal tumors. Clinical gastroenterology and hepatology 2011;9:590–594.http://www.ncbi.nlm.nih.gov/pubmed/21320641

06-06-2012

Bariatric surgery and type 2 Diabetes in obese patients:


05-23-2012

Risk for relatives of patients with serrated adenoma:

Cox-2-inhibitors and H. pylori eradication in precancerous gastric lesions:


05-09-2012

Thiopurines for prevention of colorectal neoplasia in IBD:

Indeomethacin to prevent post-ERCP pancreatitis
:


04-25-2012

Clinical details  superior to oesophageal pH-impedance to predict PPI response:

  • Zerbib et al.: Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut 2012 Apr;61(4):501-6. 
http://www.ncbi.nlm.nih.gov/pubmed/21997546

Fourthline therapy after three times eradication failure in H. pylori infection:

  • Gisbert et al.: Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Aliment. Pharmacol. Ther 2012 Apr;35(8):941-7
. http://www.ncbi.nlm.nih.gov/pubmed/22372560

04-11-2012

Budesonide in treating lymphocytic colitis:

Ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease:


03-28-2012

Peroral endoscopic myotomy in achalasia
von:

Abdominal breath exercise in gastroesophageal reflux disease:

  • 
Eherer et al: Positive Effect of Abdominal Breathing Exercise on Gastroesophageal Reflux Disease: A Randomized, Controlled Study. Am J Gastroenterol 2012; 107:372–378 
http://www.ncbi.nlm.nih.gov/pubmed/22146488

03-14-2012

Colonoscopy versus fecal imunochemical testing in colorectal-cancer screening
:

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths:

Rate and predictors of early/missed colorectal cancers after colonoscopy:

Association between colonoscopy rates and colorectal cancer mortality:


02-22-2012

Tobacco smoking as risk factor of high-grade dysplasia and cancer in Barrett’s esophagus:


02-15-2012

NSAIDs and statins as chemoprevention in Barrett's esophagus:

  • 
Kastellein et al.: Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.Gastroenterology. 2011;141:2000-8. 
http://www.ncbi.nlm.nih.gov/pubmed/21878200

in vitro gliadin challenge in difficult to diagnose celiac disease
: 


01-18-2012

The role of erythromycin in acute upper gastrointestinal hemorrhage

TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer
:


01-04-2012

Propofol vs Midazolam in sub-clinical hepatic encephalopathy:

  • 
Khamaysi et al.: Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled study. J Hepatol 2011;54:72–77. http://www.ncbi.nlm.nih.gov/pubmed/20934771

Long-term effect of Aspirin on CRC in Lynch Syndrome:

  • 
Burn et al.: Long-term eff ect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011;378:2081–87.http://www.ncbi.nlm.nih.gov/pubmed/22036019

 

  •  
  •  
  •  
  •  
© 2012-2015 Gastroenterology & Mucosal Immunology, Bern, Switzerland
Swiss Web Design